posted
I have been on bicillin for 3 months now. My vision began getting worse 2 weeks ago, and today I saw flashing lights (Freak me out). Even when I close my eyes, I saw a flashing image.
So, I saw my llmd last week, I told him about my new symtoms, he ruled out side effect from the abx, based on other new symtoms I had.
He said the medicine is getting inside my cns, in my brain (I started feeling brain tingling too, new symtpom), and that it takes a while for bicillin to get in there, but now it is working in cns.
That should make me feel better,but these new symtoms are so freaky. I feel like I am herxing though, this is a long herx.
Does this make sense, that the new symptoms are herx realted? Jenin
Posts: 455 | From Maryland | Registered: Jul 2007
| IP: Logged |
posted
I've been on Bicillin for about 2 1/2 months and am also getting new symptoms, such as muscle twitching and muscle weakness. I can barely lift my arms.
It's freaking me out too, like I'm heading in the wrong direction with the addition of new Lyme symptoms.
How much Bicillin are you on? I get two shots per week at 2.4 million units. I'm also on 300mg of Minocycline per day.
Posts: 28 | From Northern Virginia | Registered: Oct 2007
| IP: Logged |
posted
I take 3 shots per week, 1.2 million units, and am going to add in zithromax in a few weeks, after I finish taking the valtrex for my high viral titers. When I was on levaquin, I did not have any vision symtoms, all my vision stuff happened 1 month after I stopped the levaquin. Doc knows that too. I treated bart for 2 months. Doc said bart has short life, not like lyme BB. I am going to call him today , I think it is the die off, the high toxin load we have, just mobilizing around in our brain. Jenin
Posts: 455 | From Maryland | Registered: Jul 2007
| IP: Logged |
sixgoofykids
Honored Contributor (10K+ posts)
Member # 11141
posted
You might want to get checked out by an eye doctor. Flashing lights can be the first signs of a detached retina.
That being said, new symptoms can show up with treatment.
-------------------- sixgoofykids.blogspot.com Posts: 13449 | From Ohio | Registered: Feb 2007
| IP: Logged |
map1131
Frequent Contributor (5K+ posts)
Member # 2022
posted
I used to have the flashing lights, but it was only at night when I went to bed and closed my eyes and then this fireworks show would start.
No it wasn't quite that bad. But it happened alot. I used to feel it in my whole body when this happened. I told my doc that I would feel like a Christmas tree all lit up.
My central nervous system would fire up when I laid down to rest. Never understood why. It has completely gone away. That was during my late abx days sometime during 3rd year of different abx.
I gave up abx after 3+ yrs.
Pam
-------------------- "Never, never, never, never, never give up" Winston Churchill Posts: 6495 | From Louisville, Ky | Registered: Jan 2002
| IP: Logged |
lou4656
Frequent Contributor (1K+ posts)
Member # 10300
posted
Jenin -- How long did the flashing lights last. 30 minutes or so? Both eyes?
-------------------- LouLou Posts: 1276 | From maryland | Registered: Oct 2006
| IP: Logged |
treepatrol
Honored Contributor (10K+ posts)
Member # 4117
posted
There are two types of bicillin.http://www.bicillin.com/bicillin/ Also be aware
FDA Strengthens Labels of Two Specific Types of Antibiotics to Ensure Proper Use The Food and Drug Administration (FDA) announced today important labeling changes regarding Bicillin CR (penicillin G benzathine and penicillin G procaine injectable suspension) and Bicillin LA (penicillin G benzathine injectable suspension). These changes include 1) a new boxed warning against intravenous use and 2) a precautionary note for Bicillin CR explaining it is not for treatment of syphilis. King Pharmaceuticals, Inc., the manufacturer of these products, has also issued a "Dear Doctor" letter, highlighting these changes.
In addition to the new boxed warning "WARNING: NOT FOR INTRAVENOUS USE" that has been added to the labeling of both products, the same warning has been added in red, bold, all capital letters, to the Bicillin CR and Bicillin LA cartons and syringe labels. Intravascular administration of Bicillin has been associated with serious adverse effects in postmarketing reports, including cardiorespiratory arrest and death. In addition to the new boxed warning "WARNING: NOT FOR INTRAVENOUS USE" that has been added to the labeling of both products, the same warning has been added in red, bold, all capital letters, to the Bicillin CR and Bicillin LA cartons and syringe labels. Intravascular administration of Bicillin has been associated with serious adverse effects in postmarketing reports, including cardiorespiratory arrest and death.
The Centers for Disease Control and Prevention's 2002 Sexually Transmitted Diseases Treatment Guidelines recommend penicillin G benzathine for the treatment of syphilis infection, consistent with the labeled indications for Bicillin LA. However, recently King Pharmaceutical, Inc., became aware of postmarketing reports from multiple sexually transmitted disease (STD) clinics in the U.S. where Bicillin CR had been inappropriately used to treat patients infected with syphilis.
Therefore the manufacturer's "Dear Doctor" letter also reminds practitioners that Bicillin LA is the only currently approved penicillin G benzathine product indicated for the treatment of syphilis and that Bicillin CR should not be administered in place of Bicillin LA for this purpose. Administration of Bicillin CR instead of Bicillin LA in the treatment of syphilis may result in inadequate treatment.
To help health professionals better distinguish between the two types of Bicillin, King Pharmaceuticals has modified the cartons and syringe labels. The background colors for the CR cartons have been changed from white to pale green (Bicillin CR) and pale purple (Bicillin CR 900/300). Bicillin LA cartons will retain the white background. The statement "Not for the Treatment of Syphilis" has also been added in red text to both the Bicillin CR and Billin CR 900/300 syringe labels.
FDA urges health care providers and patients to report adverse event information to FDA via the MedWatch program by phone (1-800-FDA-1088), by fax (1-800-FDA-0178) or by the internet http://www.fda.gov/medwatch/index.html.
-------------------- Do unto others as you would have them do unto you. Remember Iam not a Doctor Just someone struggling like you with Tick Borne Diseases.
treepatrol
Honored Contributor (10K+ posts)
Member # 4117
posted
Louis Corsaro, MD Northern Westchester Hospital., Columbia University
Intramuscular Bicillin for Persistent Pediatric Lyme Disease L. Corsaro, M. Montemayer, B. Fallon. Northwestern Westchester Hospital, Columbia University
Objective: A preliminary study designed to evaluate the therapeutic efficacy of Benzathine penicillin given intramuscularly on a weekly basis to patients with chronic active Lyme borreliosis in a private pediatric out-patient setting.
Methods: The diagnosis of Lyme disease was based on at least one serological test along with typical articular or neurological symptoms of Lyme disease. Either LA Bicillin or CR Bicillin was administered intramuscularly on a weekly basis to patients who had relapse of clinical symptoms following oral or intravenous antibiotic therapies.
Results: Twenty-five children who have met the study criteria for seropositive disease were evaluated. All patients had failed to sustain improvement after courses of oral or intravenous antibiotic therapies. Five of these patients had received IV Rocephin and all five had failed to sustain improvement despite having received between 4 and 27 weeks of IV therapy. Symptom-free periods prior to receiving intramuscular Bicillin were evaluated with the symptom-free periods post-intramuscular Bicillin. Of the twenty-three children available to assess the relapse status after treatment, nineteen remain symptom-free, three had mild symptoms that did not require therapy and one had relapsed and was being retreated.
Conclusion: A chart review and follow-up studies suggest that intramuscular Bicillin may be particularly effective treatment for children with antibiotic refractory persistent Lyme disease whether previously treated orally or with intravenous antibiotics.
Long term treatment of chronic Lyme arthritis with benzathine penicillin.Cimmino MA, Accardo S. Dipartimento di Medicina Interna, Universit� di Genova, Genoa, Italy.
The cases are reported of two patients with chronic Lyme arthritis resistant to the recommended antibiotic regimens who were cured by long term treatment with benzathine penicillin. It is suggested that the sustained therapeutic levels of penicillin were effective either by the inhibition of germ replication or by lysis of the spirochaetes when they were leaving their sanctuaries.
PMID: 1417107 [PubMed - indexed for MEDLINE]
-------------------- Do unto others as you would have them do unto you. Remember Iam not a Doctor Just someone struggling like you with Tick Borne Diseases.
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/
UBBFriend: Email this page to someone!
Printer-friendly view of this topic